Federico Ávila-Moreno

4PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 19, 2025
SMARCB1-driven EGFR-GLI1 epigenetic alterations in lung cancer progression and therapy are differentially modulated by MEOX2 and GLI-1.

Octavio A Trejo-Villegas, Priscila Pineda-Villegas, Leonel Armas-López

|Nov 28, 2023
A PTP1B-Cdk3 Signaling Axis Promotes Cell Cycle Progression of Human Glioblastoma Cells through an Rb-E2F Dependent Pathway.

Olga Villamar-Cruz, Marco Antonio Loza-Mejía, Alonso Vivar-Sierra

|Jan 12, 2021
LncRNA SOX2-OT regulates AKT/ERK and SOX2/GLI-1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases.

Abril Marcela Herrera-Solorio, Irlanda Peralta-Arrieta, Leonel Armas López

|Jul 14, 2020
Corrigendum to "Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer".

Thalia Pacheco-Fernández, Imelda Juárez-Avelar, Oscar Illescas

Pageof 1

Frequent Collaborators

2 joint publications

Leonel Armas-López

1 joint publications

Thalia Pacheco-Fernández

1 joint publications

Imelda Juárez-Avelar

1 joint publications

Oscar Illescas